Canadian court upholds Glaxo's patent on AZT.
In October 2000, the Federal Court of Appeal issued the latest ruling in the ongoing dispute over the validity of Glaxo's Canadian patent for AZT, upholding Glaxo's patent but narrowing the scope of the claims it could validly make. The decision is now on appeal to the Supreme Court of Canada.
Elliott
R
R
D002170:Canada; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D015215:Zidovudine / Q000627:therapeutic use
D016568:Drugs, Generic; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine